genprowebdirectory
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Update Preferences
Subscribe
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Video & Multimedia
Latest News
Login
Subscribe
News
Imaging
Subcellular Map of Brain Networks Built by Combining Imaging Methods
Cancer
Z-DNA Triggering Drug Kills Immunotherapy Resistant Melanoma by Mimicking Flu
Drug Resistance
Therapeutic Target against Common Fungus Uncovered by Cryo-Electron Microscopy
Diabetes
Vitamin D Does Not Prevent Type 2 Diabetes in High Risk…
Cardiovascular Disease
Epigenetics Predicts Complications in Type 2 Diabetes Patients
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Tissue Biomanufacturing Progresses, but Still a Way to Go
Bioprocessing
Training Bioprocessors with Virtual Reality
Bioprocessing
Groundwork Established for Continuous Monitoring
Bioprocessing
Holographic Microscopy Helping Biopharma Keep an Eye on Cell Culture
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
A-Lists
Six of the Best Reports from the Front Line of Biotechnology
A-Lists
Top 10 RNA-Based Biopharmas
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Companies
Roche
Roche
23andMe
Abbott
Abbvie
AC Immune
Acorda Therapeutics
AdnaGen
Agilent Technologies
Alere
Alexion Pharmaceuticals
Amgen
Astellas
AstraZeneca
Audentes Therapeutics
Beckman Coulter
Berkeley Lights
Bio-Rad Laboratories
Biogen
BioServe Biotechnologies
Cancer Genetics
Catalent
Chan Soon-Shiong Institute for Molecular Medicine
Charles RIver Laboratories
Color Genomics
Cynvenio Biosystem
Dana-Farber Cancer Institute
deCODE genetics
Dicerna
Dimension Therapeutics
Exact Sciences
Foundation Medicine
GE Healthcare
GeneInsight
Gilead Sciences
GlaxoSmithKline
Halozyme Therapeutics
Hitachi High-Technologies
Horizon Discovery Group
Human Longevity
Illumina
Invitae
Jackson Laboratory
Janssen Biotech
LabCorp
Maravai LifeSciences
MD Anderson
MDxHealth
MedImmune
Memorial Sloan Kettering Cancer Center
Merck & Co
Merck KGaA
NanoString Technologies
Novartis
Pathology
PerkinElmer
PersonalizeDx
Qiagen
R-Biopharm
RayBiotech
Roche
Sanofi
shire
Sigma-Aldrich
Stand Up to Cancer
Synthego
Takeda
Thermo Fisher Scientific
TriLink Biotechnologies
Trovagene
UCB Biosciences
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Gene Therapy
New Spark: Successor to Build on Work of Departing CEO Jeffrey Marrazzo
Liquid Biopsies
Blood Stake: Roche Raises Freenome Investment to $360M
Cell Therapy
Lineage 2.0: Cell Therapy Developer Eyes Next Phase after Genentech Collaboration for Dry AMD
Gene Therapy
Spark Therapeutics Plans $575M Philadelphia Gene Therapy Center
Artificial Intelligence
Roche, Genentech, Recursion Launch Up-to-$12B AI Drug Discovery Effort
Roche
U.S. OKs EUA for Genentech’s Actemra vs. COVID-19; Halts Distribution of...
Roche
Mountain Climbing: Dyno Fights AAV Vector Immune Response with $100M
Roche
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Roche
Roche and Blueprint Medicines Launch Up-to-$1.7B Partnership to Develop Cancer Drug...
Roche
Phase III Trial to Study Combination of Genentech’s Actemra, Gilead’s Remdesivir...
Roche
Genentech Launches Phase III Trial of Actemra as Coronavirus Treatment
Roche
Declaring National Emergency, Trump Vows Accelerated COVID-19 Testing
Roche
Assessing Coronavirus Impact on Wall Street
Roche
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
Roche
Illumina Unveils New Sequencing Systems, Roche Clinical Dx Collaboration
1
2
3
...
5
Page 1 of 5
Scroll Up